740 related articles for article (PubMed ID: 11176565)
41. Impact of opportunistic disease on survival in patients with HIV infection.
Chaisson RE; Gallant JE; Keruly JC; Moore RD
AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
[TBL] [Abstract][Full Text] [Related]
42. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
[TBL] [Abstract][Full Text] [Related]
43. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of Opportunistic Infections and Causes of Death among Hospitalized HIV-Infected Patients in Sichuan, China.
Pang W; Shang P; Li Q; Xu J; Bi L; Zhong J; Pei X
Tohoku J Exp Med; 2018 Mar; 244(3):231-242. PubMed ID: 29563388
[TBL] [Abstract][Full Text] [Related]
46. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
[TBL] [Abstract][Full Text] [Related]
47. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
48. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
[TBL] [Abstract][Full Text] [Related]
49. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
50. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
[TBL] [Abstract][Full Text] [Related]
51. Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.
Abgrall S; Matheron S; Le Moing V; Dupont C; Costagliola D;
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):151-8. PubMed ID: 11242182
[TBL] [Abstract][Full Text] [Related]
52. Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya.
Chepkondol GK; Jolly PE; Yatich N; Mbowe O; Jaoko WG
Afr Health Sci; 2020 Jun; 20(2):615-624. PubMed ID: 33163022
[TBL] [Abstract][Full Text] [Related]
53. Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle-income Countries: A Systematic Review and Meta-analysis.
B-Lajoie MR; Drouin O; Bartlett G; Nguyen Q; Low A; Gavriilidis G; Easterbrook P; Muhe L
Clin Infect Dis; 2016 Jun; 62(12):1586-1594. PubMed ID: 27001796
[TBL] [Abstract][Full Text] [Related]
54. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
Manosuthi W; Chaovavanich A; Tansuphaswadikul S; Prasithsirikul W; Inthong Y; Chottanapund S; Sittibusaya C; Moolasart V; Termvises P; Sungkanuparph S
J Infect; 2007 Nov; 55(5):464-9. PubMed ID: 17714788
[TBL] [Abstract][Full Text] [Related]
55. Update on opportunistic infections in the era of effective antiretroviral therapy.
Zanoni BC; Gandhi RT
Infect Dis Clin North Am; 2014 Sep; 28(3):501-18. PubMed ID: 25151568
[TBL] [Abstract][Full Text] [Related]
56. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
57. Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in Shanghai.
Luo B; Sun J; Cai R; Shen Y; Liu L; Wang J; Zhang R; Shen J; Lu H
Medicine (Baltimore); 2016 May; 95(21):e3802. PubMed ID: 27227959
[TBL] [Abstract][Full Text] [Related]
58. Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.
Weissberg D; Mubiru F; Kambugu A; Fehr J; Kiragga A; von Braun A; Baumann A; Kaelin M; Sekaggya-Wiltshire C; Kamya M; Castelnuovo B
PLoS One; 2018; 13(11):e0206796. PubMed ID: 30383836
[TBL] [Abstract][Full Text] [Related]
59. Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
Arefaine ZG; Abebe S; Bekele E; Adem A; Adama Y; H Brockmeyer N; Coenenberg J; Potthoff A; Gebremeskel TG
PLoS One; 2020; 15(4):e0229757. PubMed ID: 32310961
[TBL] [Abstract][Full Text] [Related]
60. Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Makumbi F
BMC Public Health; 2016 Aug; 16(1):766. PubMed ID: 27515983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
